Results 1 to 10 of about 30,735 (203)

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report

Journal of Medical Case Reports, 2017
Background In recent reports, re-irradiation with stereotactic body radiotherapy for lung tumors in patients previously treated with thoracic radiation therapy resulted in several serious toxicities.
Hotaka Nonaka, Hiroshi Onishi, Masatoki Ozaki, Kengo Kuriyama, Takafumi Komiyama, Ryo Saito   +5 more
doaj   +2 more sources

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

Frontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani, Giovanni eAguzzi, David eSchaal, Pantaleo eRomanelli   +3 more
doaj   +2 more sources

Stereotactic body radiotherapy in lung cancer: an update

Jornal Brasileiro de Pneumologia, 2015
For early-stage lung cancer, the treatment of choice is surgery. In patients who are not surgical candidates or are unwilling to undergo surgery, radiotherapy is the principal treatment option.
Carlos Eduardo Cintra Vita Abreu, Paula Pratti Rodrigues Ferreira, Fabio Ynoe de Moraes, Wellington Furtado Pimenta Neves Jr, Rafael Gadia, Heloisa de Andrade Carvalho   +5 more
doaj   +2 more sources

Highlights on the Management of Oligometastatic Disease [PDF]

Journal of Immunotherapy and Precision Oncology, 2020
Purpose: The understanding of oligometastatic disease (OMD) is rapidly evolving and with this comes the ability to utilize a number of modalities that excel in the localized control of disease.
Salem M. Alshehri, Khaled Alkattan, Ahmed Abdelwarith, Hussain Alhussain, Shaker Shaker, Majed Alghamdi, Hossam Alassaf, Ali Albargawi, Manal Al Naimi, Ameen Alomair, Saif Althaqfi, Adnan Alhebshi, Majid Alothman, AbdulRahman Jazieh   +13 more
doaj   +1 more source

Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis.

PLoS ONE, 2021
Previous studies have reported conflicting results for the effect of overall treatment time with stereotactic body radiotherapy on tumor control in early-stage non-small-cell lung cancer.
Toshiki Ikawa, Takahiro Tabuchi, Koji Konishi, Masahiro Morimoto, Takero Hirata, Naoyuki Kanayama, Kentaro Wada, Masayasu Toratani, Sumiyo Okawa, Kazuhiko Ogawa, Teruki Teshima   +10 more
doaj   +1 more source

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report

Journal of Medical Case Reports, 2022
Background Hematomas that slowly increase in size for more than 1 month after the initial hemorrhage are referred to as chronic expanding hematomas. Chronic expanding hematoma can also occur after radiosurgery; however, there have been no reports about ...
Yojiro Ishikawa, Takaya Yamamoto, Rei Umezawa, Noriyoshi Takahashi, Kazuya Takeda, Yu Suzuki, Keiichi Jingu   +6 more
doaj   +1 more source

Stereotactic radiotherapy: An alternative option for refractory ventricular tachycardia to drug and ablation therapy [PDF]

, 2022
Refractory ventricular tachycardia (VT) often occurs in the context of organic heart disease. It is associated with significantly high mortality and morbidity rates.
Shangguan, Wenfeng, Liu, Xingpeng, Liu, Tong, Wang, Xin, Zhang, Nan, Li, Guangping, Tse, G., Xu, Gang   +7 more
core   +1 more source

Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy. [PDF]

, 2020
This review details and discusses the technological quality requirements to ensure the desired quality for stereotactic radiotherapy using photon external beam radiotherapy as defined by the DEGRO Working Group Radiosurgery and Stereotactic Radiotherapy ...
Baus, Wolfgang W., Werner, Rene, Loutfi-Krauss, Britta, Fix, Michael K., Gauer, Tobias, Baus, Wolfgang W, Brunner, Thomas B, Manser, Peter, Fleckenstein, Jens, Schmitt, Daniela, Brunner, Thomas B., Moustakis, Christos, Blanck, Oliver, Wilhelm, Maria-Lisa   +13 more
core   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

Thoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source